IFP Advisors, Inc - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2022$521,000
+0.2%
11,173
-0.6%
0.01%
-12.5%
Q2 2022$520,000
-37.3%
11,241
-37.7%
0.02%
+60.0%
Q1 2022$830,000
+248.7%
18,056
+237.9%
0.01%
+100.0%
Q4 2021$238,000
+22.7%
5,343
+5.1%
0.01%
+25.0%
Q3 2021$194,0000.0%5,085
+3.6%
0.00%0.0%
Q2 2021$194,000
+7.8%
4,910
-2.1%
0.00%0.0%
Q1 2021$180,000
-12.6%
5,016
-10.4%
0.00%
-50.0%
Q4 2020$206,000
-8.4%
5,600
-5.3%
0.01%
-38.5%
Q3 2020$225,000
-1.7%
5,912
+4.9%
0.01%
-27.8%
Q2 2020$229,000
+4.1%
5,635
-4.8%
0.02%
-18.2%
Q1 2020$220,000
-39.4%
5,919
-23.4%
0.02%
-18.5%
Q4 2019$363,000
-3.7%
7,727
-13.6%
0.03%
+8.0%
Q3 2019$377,000
+19.3%
8,945
+17.2%
0.02%
-41.9%
Q1 2019$316,000
-74.9%
7,631
-76.9%
0.04%
-44.2%
Q4 2018$1,260,000
-16.1%
33,034
-11.6%
0.08%
+26.2%
Q3 2018$1,502,000
+43.3%
37,384
+43.8%
0.06%
+38.6%
Q2 2018$1,048,000
+7.9%
25,996
-5.0%
0.04%0.0%
Q1 2018$971,0000.0%27,3620.0%0.04%0.0%
Q4 2017$971,000
-42.6%
27,362
-34.3%
0.04%
-34.3%
Q3 2017$1,691,000
-8.8%
41,643
-3.1%
0.07%
-15.2%
Q2 2017$1,854,000
+7.7%
42,988
+5.3%
0.08%
+5.3%
Q1 2017$1,722,000
+13.1%
40,841
+3.2%
0.08%
+2.7%
Q4 2016$1,523,000
+4.5%
39,561
+17.1%
0.07%
-3.9%
Q3 2016$1,457,000
+6.6%
33,777
+7.1%
0.08%0.0%
Q2 2016$1,367,000
+332.6%
31,542
+313.3%
0.08%
+76.7%
Q1 2016$316,000
-64.1%
7,631
-65.0%
0.04%
-27.1%
Q4 2015$879,00021,7740.06%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2018
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 1,282,289$46,483,4037.25%
Columbia Asset Management 9,960$3610.08%
PARK CIRCLE Co 800$29,0000.03%
PARADIGM ASSET MANAGEMENT CO LLC 1,800$65,2500.02%
Byrne Asset Management LLC 56$2,0000.00%
Retirement Group, LLC 40$1,4500.00%
Bartlett & Co. LLC 240$90.00%
HUNTINGTON NATIONAL BANK 1$400.00%
View complete list of GLAXOSMITHKLINE PLC shareholders